AMSbiopharma and LEF announce strategic partnership to expand service offering
AMSbiopharma is pleased to announce a new strategic partnership with LEF, a CRO and CDMO based in Portugal and part of the National Association of Pharmacies (ANF) Group. This partnership will allow both companies to complement each other’s strengths and expand the range of services they offer to the pharmaceutical industry.
By joining forces, AMSbiopharma and LEF will leverage their combined expertise and resources to offer enhanced solutions and innovative services in the biopharmaceutical industry.
In this way, this partnership aims to provide our customers with comprehensive support, from early-stage research and development to full-scale production and commercialization.
‘This agreement allows us to expand our service offering with a great partner like LEF and to maintain our strategic agenda and international development,’ says Marcos Engroba, Sales Manager of AMSbiopharma.
‘We are delighted to partner with AMSbiopharma,’ said Fátima Godinho Carvalho, Executive Director of LEF. ‘This collaboration is a significant step forward in our mission to provide exceptional value and comprehensive services to our customers. Together, we are better equipped to meet the evolving needs of the pharmaceutical sector.’
LEF shares our commitment to excellence and innovation, and together we look forward to delivering valuable results for our clients.
About LEF:
LEF’s services extend to various sectors, including Pharmaceuticals, Medical Cannabis, Veterinary Industry, among others.
Their 2400 m2 GMP facility allows them to offer a wide range of services, such as:
- Pharmaceutical development and manufacturing (liquids, semi-solids and solids; pilot scale)
- Analytical development and validation
- Quality and stability control
- Microbiological control
- New product introduction
- EU batch certification/import
- Toxicological support (risk analysis, PDE reports and impurity assessment)
- Regulatory affairs and pharmacovigilance
- Quality consultancy
- Investigational medicinal products
- Medical Cannabis
- Pharmaceutical support and compounding
They offer innovative and multidisciplinary scientific services at the forefront of the pharmaceutical sector, faithful to their core values – Knowledge, Sustainability, Innovation and Credibility. LEF is a registered trademark of INFOSAÚDE – INSTITUTO DE FORMAÇÃO E INOVAÇÃO EM SAÚDE, S.A., holder of all certifications and licenses.
About AMSbiopharma:
AMSbiopharma is an analytical CRO offering advanced services for the chemical, pharmaceutical and biopharmaceutical industries. We are fully oriented to the customer and his needs, offering not only standard analytical solutions, but also specific solutions for problems that arise during new developments or, for example, during audits.
Today, AMSBiopharma serves numerous companies, assisting them in their problem-solving processes as well as in their routine work with small molecules. We are a close laboratory, with easy communication and whose support has allowed us to grow significantly over the years, and we are in the process of expansion, to become a reference for services in Europe.
AMSbiopharma offers a wide range of services, such as:
- Organic drug impurities
- Analytical support
- Bioanalytical services
- Analysis of protein-based pharmaceuticals
- Analysis of nucleic acid-based biopharmaceuticals
- Metabolomics services